DrugPatentWatch

Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Tradename: DIGOXIN

Summary for Tradename: DIGOXIN

Patents:0
Applicants:11
NDAs:13
Suppliers: see list3
drug
patent expirations by year for
 DIGOXIN

Pharmacology for Tradename: DIGOXIN

Ingredient-typeCardiac Glycosides
Drug ClassCardiac Glycoside

Clinical Trials for: DIGOXIN

Digoxin Dosing in Heart Failure: A Simplified Nomogram Versus Standard Care
Status: Completed Condition: Heart Failure

Study to Evaluate the Effect of Solifenacin and Mirabegron on the Digoxin Concentrations in Blood in Healthy Subjects
Status: Completed Condition: Healthy Subjects; Pharmacokinetics; Drug-Drug Interaction (DDI)

Drug Interaction Study of Isavuconazole and Digoxin
Status: Completed Condition: Pharmacokinetics of Isavuconazole; Pharmacokinetics of Digoxin; Healthy Volunteers

Drug Interaction Study of Digoxin and BI 10773
Status: Completed Condition: Healthy

A Phase 1 Study Evaluating Eliglustat's Effects on Pharmacokinetics, Safety & Tolerability of Digoxin in Healthy Adults
Status: Completed Condition: Healthy Volunteer

to Evaluate Effect of Multi Doses Flibans 100 mg Film-c Tablets on Single Dose PK of Digoxin 0.5 mg, Healthy Volunteers
Status: Completed Condition: Healthy

An Open-label, Single-centre Study Evaluating the Pharmacokinetics of Digoxin Alone and When Administered at Various Doses of Ezogabine/Retigabine in Healthy Adults. The Pharmacokinetics of Ezogabine/Retigabine and the N-acetyl Metabolite of Ezogabine/Retigabine (NAMR) Will Also be Assessed
Status: Completed Condition: Epilepsy

A Study to Investigate the Effect of Steady-State TMC278 on the Pharmacokinetics of a Single Dose of Digoxin
Status: Completed Condition: Healthy

A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics and Safety of Digoxin in Healthy Volunteers.
Status: Completed Condition: Healthy

Study in Healthy Volunteers to Assess the Pharmacokinetics (PK) of Digoxin Administered Alone and in Combination With Vandetanib
Status: Completed Condition: Healthy Volunteers

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abraxis Pharm
DIGOXIN
digoxin
INJECTABLE;INJECTION083217Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
Caraco
DIGOXIN
digoxin
TABLET;ORAL076363Jan 31, 2003DISCNNo<disabled><disabled>
Hikma Maple
DIGOXIN
digoxin
INJECTABLE;INJECTION083391Approved Prior to Jan 1, 1982RXNo<disabled><disabled>
Hikma Pharms
DIGOXIN
digoxin
TABLET;ORAL077002Oct 30, 2007RXNo<disabled><disabled>
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011  2012  2013 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology

`abc